Nationwide Cohort to Estimate Burden of Respiratory Viruses and Immunologic Response (Blood Donor Cohort)
ID: 350452Type: Posted
Overview

Buyer

Centers for Disease Control and Prevention - ERA (HHS-CDC-HHSCDCERA)

Award Range

$3M - $5M

Eligible Applicants

For-Profit Organizations

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/350452
Timeline
    Description

    The Centers for Disease Control and Prevention (CDC) is offering a cooperative agreement to establish a nationwide longitudinal cohort of repeat blood donors aimed at estimating the burden of respiratory viruses and assessing immunologic responses. The project will involve monitoring changes in antibody titers against various respiratory viruses, surveying donors for risk factors, and creating a repository for future analysis as new assays are developed. This initiative builds on previous national serosurveillance studies conducted during the COVID-19 pandemic and seeks to adapt those methodologies to evaluate the national burden of SARS-CoV-2 and other respiratory viruses. Interested applicants can apply for funding ranging from $3 million to $4.5 million, with a total program funding of $26.5 million available, and must submit their applications by February 16, 2024. For further inquiries, contact Dr. Jamal Bankhead at JBankhead@cdc.gov.

    Point(s) of Contact
    JBankhead@cdc.gov
    Files
    No associated files provided.
    Similar Opportunities
    Collaborative Surveys to Provide Inputs into Vaccine-Related Economic Evaluations
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity titled "Collaborative Surveys to Provide Inputs into Vaccine-Related Economic Evaluations" through a cooperative agreement. This initiative aims to support research that gathers timely economic data on immunization from nationally representative samples of the public, including patients and caregivers, to inform economic evaluations of new vaccines. The program is critical for understanding productivity losses related to immunization, particularly for vulnerable populations such as pregnant women and parents of young children. The estimated total funding for this program is $1.2 million, with individual awards ranging from $300,000 to $400,000. Interested applicants can reach out to Amy Yang at AYang@cdc.gov or by phone at 404-718-8836, with applications due by March 31, 2026, and project start anticipated on September 1, 2026.
    Building National Partnerships for the Prevention of Emerging and Reemerging Infectious Diseases
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is offering a cooperative agreement titled "Building National Partnerships for the Prevention of Emerging and Reemerging Infectious Diseases." This initiative aims to enhance the nation's capacity to prevent, detect, and respond to infectious disease threats by supporting healthcare professionals, systems, and organizations involved in public health and patient care. The program emphasizes strengthening critical infrastructure, workforce training, and emergency response capabilities, particularly focusing on antimicrobial resistance and infection control. With an estimated total funding of $150 million, the CDC anticipates awarding approximately 15 grants, with individual awards ranging from $1 million to $30 million. Interested applicants can contact Trisia Shannon at 404-639-0063 or via email at xki5@cdc.gov, with applications due by April 18, 2026, and project start dates expected by September 30, 2026.
    Economic and Modeling Analyses to Support Immunization Policy and Programs
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a cooperative agreement for research projects aimed at developing economic and modeling analyses to support immunization policy and programs. The primary objective is to generate robust data and model-based evidence regarding the public health and economic impacts of vaccines, which will assist decision-makers in enhancing immunization strategies for various populations. This funding opportunity is critical for addressing the burden of vaccine-preventable diseases and promoting cost-effective vaccination interventions, ultimately aiming to save lives and reduce healthcare costs. The estimated total program funding is $3,750,000, with individual awards ranging from $500,000 to $750,000, and applications are due by March 1, 2026. For further inquiries, interested applicants can contact Amy Yang at AYang@cdc.gov or by phone at 404-718-8836.
    Influenza Modeling and Forecasting
    Centers for Disease Control - NCIRD
    The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity titled "Influenza Modeling and Forecasting" through a cooperative agreement aimed at enhancing the use of influenza modeling and forecasting to improve public health responses. The initiative seeks to establish a network that will provide situational awareness, inform prevention and control strategies, and advance the science of influenza forecasting, particularly for populations disproportionately affected by influenza. With an estimated total program funding of $14,750,000 and the expectation of awarding seven grants, interested applicants can reach out to Rebecca Borchering at 404.639.5214 or via email at xkq2@cdc.gov. Applications must be submitted electronically by February 2, 2026, with awards anticipated to be made by August 1, 2026.
    Continuation and Expansion of the National Mesothelioma Virtual Bank for Translational Research (U24)
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity for the continuation and expansion of the National Mesothelioma Virtual Bank for Translational Research (U24). This cooperative agreement aims to enhance the collection of biospecimens and related data to support biomedical research on malignant mesothelioma, requiring applicants to have an established registry and tissue bank capable of functioning as a national resource. The initiative is crucial for advancing research into early disease markers, treatment modalities, and improving health outcomes for mesothelioma patients. The total estimated funding for this program is $5.5 million, with a ceiling and floor award amount of $1.1 million, and applications must be submitted electronically by March 23, 2026, with an anticipated award date of August 1, 2026. For further inquiries, interested parties can contact Bridgette Garrett at bgarrett@cdc.gov or by phone at 770-488-5715.
    Reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities.
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is offering a federal grant opportunity aimed at reducing the burden of parasitic infections in the United States through evidence-based prevention and control activities. This initiative seeks applications from bona fide agents representing state, territorial, local, and tribal government organizations, with the goal of implementing effective strategies to combat parasitic diseases. The total estimated program funding is $23,750,000, with individual awards ranging from $250,000 to $1,250,000, and a total of 11 awards expected to be made. Interested applicants should note that the application deadline is June 5, 2026, and they can reach out to Jamal Choice, the Project Officer, at 404.718.8228 or via email at qhi2@cdc.gov for further information.
    Strengthening and Developing of Sustainable Global Public Health and Epidemiological Workforce Capacity through Collaboration, Program Development, and Implementation
    Centers for Disease Control-GHC
    The Centers for Disease Control and Prevention (CDC) is offering a cooperative agreement aimed at strengthening and developing sustainable global public health and epidemiological workforce capacity through collaboration, program development, and implementation. This initiative seeks to address public health workforce development needs, enhance the ability to prevent, detect, and respond to diseases, and strengthen epidemiologic workforce capacity at a global level, particularly in light of recent public health threats such as COVID-19 and Ebola. The total estimated funding for this program is $100 million, with an expected three awards to be made, and applications must be submitted electronically by January 2, 2026, to be considered. For further inquiries, interested applicants can contact Broderick Yoerg at 404.234.0666 or via email at DGHPNOFOs@cdc.gov.
    Promoting World Trade Center Health Program Youth Research Cohort Recruitment and Retention Using Principles of Community Engaged Research (CEnR) to Build Community Participation (U01)
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is inviting applications for the Promoting World Trade Center Health Program Youth Research Cohort Recruitment and Retention project, aimed at enhancing community engagement through Community Engaged Research (CEnR) principles. The initiative seeks to establish authentic partnerships between communities and health researchers to effectively recruit and retain participants, particularly young survivors and advocacy organizations, while evaluating the effectiveness of pilot studies throughout the process. This funding opportunity, categorized as a discretionary federal grant, offers a total estimated program funding of $24 million, with individual awards ranging from $0 to $1 million, and is expected to support approximately six projects. Interested applicants can reach out to Eduardo O'Neill, PhD, at 404-718-8844 or via email at fzt4@cdc.gov for further information, with applications due by 5:00 PM local time on February 12, 2026.
    Enhancing Global Health Security: Strengthening public health surveillance systems for disease detection and preparedness globally
    Centers for Disease Control-GHC
    The Centers for Disease Control and Prevention (CDC) is offering a cooperative agreement opportunity titled "Enhancing Global Health Security: Strengthening public health surveillance systems for disease detection and preparedness globally." This initiative aims to bolster global health security by enhancing public health surveillance systems, improving workforce capabilities, and integrating surveillance data into actionable insights for decision-making. The program is critical for developing regional and country capacities to detect and respond to infectious diseases and other public health threats. The estimated total funding for this opportunity is $15 million, with two awards expected, and applications must be submitted electronically by April 16, 2026. For further inquiries, interested applicants can contact Broderick Yoerg at 404.234.0666 or via email at DGHPNOFOs@cdc.gov.
    Strengthening and Development of Sustainable Regional Public Health and Epidemiological Workforce Capacity through Collaboration, Program Development, and Implementation
    Centers for Disease Control-GHC
    The Centers for Disease Control and Prevention (CDC) is offering a cooperative agreement aimed at strengthening and developing sustainable regional public health and epidemiological workforce capacity through collaboration, program development, and implementation. This initiative seeks to address public health workforce development needs, enhance the capacity to prevent, detect, and respond to diseases, and improve public health priorities, particularly in light of recent global health threats such as COVID-19 and Ebola. The program will focus on collaboration among public health institutions and Ministries of Health at regional and country levels, with an estimated total funding of $75 million available for three expected awards. Interested applicants can reach out to Broderick Yoerg at 404.234.0666 or via email at DGHPNOFOs@cdc.gov, with applications due by January 2, 2026, and project start anticipated by September 30, 2026.